CUROSURF 80 MG 80 MG SUSPENSION

CUROSURF 80 MG

Active Ingredient:
PORACTANT ALFA
Form:
SUSPENSION
Brand:
CUROSURF
Origin:
ITALY

Buy CUROSURF 80 MG PORACTANT ALFA

Curosurf 80 mg is a poractant alfa suspension used for respiratory support in premature infants. This intratracheal medication helps improve lung function and reduce respiratory distress.

Strength

80 MG

Manufacturer / TM Owner

CHIESI FARMACEUTICI S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Curosurf 80 mg is primarily used to treat respiratory distress syndrome (RDS) in premature infants. This condition occurs when the lungs are not fully developed, leading to difficulty in breathing. Poractant alfa, the active ingredient, works by replacing the natural surfactant in the lungs, which helps the lungs expand and function more effectively. What is Curosurf used for? It is specifically designed for intratracheal administration to provide immediate respiratory support.

Side Effects

  • Common effects of Curosurf 80 mg may include improved lung function and reduced need for mechanical ventilation. Some infants may experience temporary side effects such as mild respiratory discomfort or changes in oxygen levels. These effects are generally monitored and managed by healthcare professionals.

Precautions & Warnings

  • Curosurf 80 mg should be administered only by trained healthcare professionals in a controlled medical setting. It is important to follow proper handling and storage guidelines to maintain the efficacy of the suspension. Always consult a healthcare provider for specific precautions and contraindications.

Avoid Interactions

  • Curosurf 80 mg may interact with other medications or treatments administered intratracheally. It is important to inform healthcare providers about all current medications to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this medication.

References

Frequently Asked Questions

Curosurf 80 mg is used to treat respiratory distress syndrome (RDS) in premature infants by replacing natural surfactant in the lungs.

Curosurf is administered intratracheally by trained healthcare professionals in a controlled medical setting.

Common effects include improved lung function and reduced need for mechanical ventilation, with some infants experiencing mild respiratory discomfort.

Yes, Curosurf should be administered by trained professionals, and proper handling and storage guidelines should be followed.

Yes, it may interact with other intratracheal medications, so it's important to inform healthcare providers about all current treatments.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT